These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10082049)

  • 21. Personalized cancer vaccines.
    Jain KK
    Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy and gastrointestinal cancer: concepts and clinical facts.
    Hauses M; Schackert HK
    Langenbecks Arch Surg; 1999 Oct; 384(5):479-88. PubMed ID: 10552295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in strategies and methodologies in cancer immunotherapy.
    Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
    Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy in human glioblastoma.
    Szabo AT; Carpentier AF
    Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas.
    Tanaka F; Haraguchi N; Isikawa K; Inoue H; Mori M
    Oncol Rep; 2008 Nov; 20(5):1111-6. PubMed ID: 18949409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considerations on clinical use of T cell immunotherapy for cancer.
    Plautz GE; Cohen PA; Shu S
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):245-57. PubMed ID: 12956434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-based cancer vaccines: an ex vivo approach.
    Van Tendeloo VF; Van Broeckhoven C; Berneman ZN
    Leukemia; 2001 Apr; 15(4):545-58. PubMed ID: 11368356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.
    Bhargava A; Bunkar N; Khare NK; Mishra D; Mishra PK
    Nanomedicine (Lond); 2014 Jul; 9(14):2187-202. PubMed ID: 25405796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.
    Markiewicz MA; Kast WM
    Cancer Invest; 2004; 22(3):417-34. PubMed ID: 15493363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.
    Sheikhi A; Jafarzadeh A; Kokhaei P; Hojjat-Farsangi M
    Iran J Immunol; 2016 Sep; 13(3):148-66. PubMed ID: 27671507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer immunotherapy--current status].
    Kundig TM; Renner Ch; Knuth A
    Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy of hepatocellular carcinoma and gastrointestinal tumors.
    Sangro B; Qian C; Schmitz V; Prieto J
    Ann N Y Acad Sci; 2002 Jun; 963():6-12. PubMed ID: 12095923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy for melanoma.
    Komenaka I; Hoerig H; Kaufman HL
    Clin Dermatol; 2004; 22(3):251-65. PubMed ID: 15262312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of dendritic cell vaccines.
    Morse MA; Lyerly HK
    Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
    Anguille S; Smits EL; Bryant C; Van Acker HH; Goossens H; Lion E; Fromm PD; Hart DN; Van Tendeloo VF; Berneman ZN
    Pharmacol Rev; 2015 Oct; 67(4):731-53. PubMed ID: 26240218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive cellular therapy of malignancy.
    Chang AE; Geiger JD; Sondak VK; Shu S
    Arch Surg; 1993 Nov; 128(11):1281-90. PubMed ID: 8239992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging immunotherapies in ovarian cancer.
    Ojalvo LS; Nichols PE; Jelovac D; Emens LA
    Discov Med; 2015 Sep; 20(109):97-109. PubMed ID: 26463091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.